Standards of Care in Diabetes2026, Retinopathy section
Baba S, Iwasa M, Higashi K, Minatoguchi S, Yamada Y, Kanamori H, Kawasaki M, Nishigaki K, Minatoguchi S (2017) Antidiabetic drug alogliptin protects the heart against ischemia-reperfusion injury through GLP-1 receptor-dependent and receptor-independent pathways involving nitric oxide production in rabbits
Effects of creams containing vitamin C, a copper-binding peptide cream and melatonin compared with tretinoin on the ultrastructure of normal skinA pilot clinical, histologic, and ultrastructural study
What the Data Shows The honest answer, based on the published evidence, is mixed rather than negative
People who take GLP-1 medications for several years may face a higher risk of developing osteoporosis, gout, and osteomalacia, according to new research presented Monday at the annual meeting of the American Academy of Orthopaedic Surgeons
"And we are seeing multiple reports of this as well," she said